DK0557305T3 - (2-thienyl) alkylaminoacetamidderivater med neurobeskyttende egenskaber - Google Patents
(2-thienyl) alkylaminoacetamidderivater med neurobeskyttende egenskaberInfo
- Publication number
- DK0557305T3 DK0557305T3 DK91918183.4T DK91918183T DK0557305T3 DK 0557305 T3 DK0557305 T3 DK 0557305T3 DK 91918183 T DK91918183 T DK 91918183T DK 0557305 T3 DK0557305 T3 DK 0557305T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- hydrogen
- amino
- represents hydrogen
- represent
- Prior art date
Links
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 title 1
- 230000000324 neuroprotective effect Effects 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 7
- 229910052739 hydrogen Inorganic materials 0.000 abstract 7
- 239000001257 hydrogen Substances 0.000 abstract 7
- 150000002431 hydrogen Chemical group 0.000 abstract 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- -1 mercaptomethyl Chemical group 0.000 abstract 3
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 abstract 1
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 abstract 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical group O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical group O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58987990A | 1990-09-26 | 1990-09-26 | |
| US07/589,963 US5109017A (en) | 1990-09-26 | 1990-09-26 | (2-thienyl)alkylamine derivatives having neuroprotective properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0557305T3 true DK0557305T3 (da) | 1997-09-08 |
Family
ID=27080687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91918183.4T DK0557305T3 (da) | 1990-09-26 | 1991-09-24 | (2-thienyl) alkylaminoacetamidderivater med neurobeskyttende egenskaber |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0557305B1 (da) |
| JP (1) | JP3108433B2 (da) |
| AT (1) | ATE154349T1 (da) |
| DE (1) | DE69126537T2 (da) |
| DK (1) | DK0557305T3 (da) |
| ES (1) | ES2103004T3 (da) |
| GR (1) | GR3024553T3 (da) |
| HU (1) | HU211322A9 (da) |
| IE (1) | IE913279A1 (da) |
| PT (1) | PT99050B (da) |
| WO (1) | WO1992005169A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0516978A1 (de) * | 1991-05-03 | 1992-12-09 | Hoechst Aktiengesellschaft | Enantiomere von substituierten (Aminophenyl)--hetroarylethylaminen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| FR2751652B1 (fr) * | 1996-07-24 | 1998-09-04 | Expansia Sa | Derives du thienylcyclohexane, des procedes pour leur preparation et leur utilisation en tant que produits industriels nouveaux pour la synthese de derives thienylcyclohexyles |
| DE19963175A1 (de) * | 1999-12-27 | 2001-07-12 | Gruenenthal Gmbh | Verwendung von substituierten 4-Amino-1-phenylbutan-2-ol-Verbindungen als Arzneimittel |
| DE10025238A1 (de) | 2000-05-22 | 2001-11-29 | Gruenenthal Gmbh | Verwendung substituierter 1-Amino-5-phenylpentan-3-ol- und/oder 1-Amino-6-phenylhexan-3-ol- Verbindungen als Arzneimittel |
| DK1368336T3 (da) * | 2001-02-16 | 2006-10-02 | Allelix Neuroscience Inc | Thiophensubstituerede aminderivater som GlyT-1-inhibitorer |
| KR101014095B1 (ko) | 2004-12-31 | 2011-02-14 | 코퍼트 비.브이. | 응애 조성물, 그의 용도, 포식성 이리응애인지중해이리응애의 사육 방법, 상기 이리응애를 사육하는사육 시스템 및 작물에서의 생물학적 해충 방제 방법 |
| NZ555985A (en) | 2004-12-31 | 2009-11-27 | Koppert Bv | Mite composition, use thereof, method for rearing a phytoseiid predatory mite, rearing system, for rearing said phytoseiid predatory mite and methods for biological pest control on a crop |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL86740A (en) * | 1987-06-30 | 1992-11-15 | Tanabe Seiyaku Co | Thiphene derivatives,their preparation and pharmaceutical compositions containing them |
| JPS6416778A (en) * | 1987-07-09 | 1989-01-20 | Tanabe Seiyaku Co | Thiophene derivative |
| EP0322582A3 (en) * | 1987-12-07 | 1989-09-13 | Hoechst-Roussel Pharmaceuticals Incorporated | 4-heteroaryl-1,3-benzodiazepines and 2-substituted-alpha-(heteroaryl)benzeneethanamines, a process for their preparation and their use us medicaments |
| ES2051927T3 (es) * | 1988-06-14 | 1994-07-01 | Searle & Co | 1,2-diariletilaminas para el tratamiento de daños neurotoxicos. |
-
1991
- 1991-09-17 IE IE327991A patent/IE913279A1/en not_active IP Right Cessation
- 1991-09-24 AT AT91918183T patent/ATE154349T1/de not_active IP Right Cessation
- 1991-09-24 DK DK91918183.4T patent/DK0557305T3/da active
- 1991-09-24 JP JP03516769A patent/JP3108433B2/ja not_active Expired - Fee Related
- 1991-09-24 EP EP91918183A patent/EP0557305B1/en not_active Expired - Lifetime
- 1991-09-24 DE DE69126537T patent/DE69126537T2/de not_active Expired - Fee Related
- 1991-09-24 ES ES91918183T patent/ES2103004T3/es not_active Expired - Lifetime
- 1991-09-24 WO PCT/US1991/006951 patent/WO1992005169A1/en active IP Right Grant
- 1991-09-25 PT PT99050A patent/PT99050B/pt not_active IP Right Cessation
-
1995
- 1995-06-27 HU HU95P/P00460P patent/HU211322A9/hu unknown
-
1997
- 1997-08-27 GR GR970402192T patent/GR3024553T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2103004T3 (es) | 1997-08-16 |
| WO1992005169A1 (en) | 1992-04-02 |
| DE69126537T2 (de) | 1997-10-02 |
| PT99050B (pt) | 1999-02-26 |
| PT99050A (pt) | 1992-08-31 |
| DE69126537D1 (de) | 1997-07-17 |
| JPH06501472A (ja) | 1994-02-17 |
| EP0557305B1 (en) | 1997-06-11 |
| ATE154349T1 (de) | 1997-06-15 |
| JP3108433B2 (ja) | 2000-11-13 |
| GR3024553T3 (en) | 1997-12-31 |
| HU211322A9 (en) | 1995-11-28 |
| EP0557305A1 (en) | 1993-09-01 |
| IE913279A1 (en) | 1992-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20010482A1 (es) | Derivados de 3-ureido-pirazol y procedimiento para su preparacion | |
| ATE339409T1 (de) | Trizyklische verbindungen | |
| NO900542D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzokondenserte n-holdige heterocykliske derivater. | |
| ES2132284T3 (es) | Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa. | |
| NO975666L (no) | Pyrrolderivater og medisinsk sammensetning | |
| DZ1694A1 (fr) | "n-(2-Aminoethyl)-benzothialozones". | |
| DK0565377T3 (da) | Terapeutiske midler til behandling af Parkinsons sygdom | |
| SE9703377D0 (sv) | New compounds | |
| DE69724140D1 (de) | Pyridoncarbonsäurederivate oder ihre salze und diese als aktive bestandteile enthaltende medikamente | |
| DK0557305T3 (da) | (2-thienyl) alkylaminoacetamidderivater med neurobeskyttende egenskaber | |
| DK26289D0 (da) | Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia | |
| PT86677A (pt) | Process for the preparation of cinnoline-carboxamides and of pharmaceutical compositions containing the same | |
| ATE114301T1 (de) | N-(mercaptoalkyl) harnstoffe und carbamate. | |
| DK613687D0 (da) | Kondenserede heterocycliske tetrahydroaminoquinolinoler og beslaegtede forbindelser, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler | |
| NO903390L (no) | Fremgangsmaate for fremstilling av 2,3-dihydro-1-(pyridinylamino)-indoler og deres anvendelse som legemidler. | |
| HUT75649A (en) | Optically active imidazolidinone derivative and pharmaceutical compositions containing them | |
| DK0485219T3 (da) | Lægemidler til forebyggelse og behandling af kredsløbsorgansygdomme indeholdende spiro-3-heteroazolidinforbindelser | |
| DE69230498D1 (de) | 2-Pyrazinylethylamin-Derivate und ihre Verwendung als Arzneimittel. | |
| DE69428206D1 (de) | Chinolincarbonsäurederivate und ihre salze | |
| DK592589D0 (da) | Kondenserede heterocycliske derivater af 1,2,3,4-tetrahydroacridin, deres fremstilling og anvendelse | |
| DE69620175D1 (de) | Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend | |
| NZ534600A (en) | Substituted isoquinoline derivatives and their use as anticonvulsants | |
| BR0104344A (pt) | Análagos de fenoxazina úteis como inibidores de agregação amilóide e tratamento da doença de alzheimer e de disfunções relacionadas com a amiloidose | |
| DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
| DK0401779T3 (da) | 4,5,5a,6-Tetrahydro-3H-isoazolo(5,4,3-kl)acridinderivater, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler |